HUP0102702A2 - Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases - Google Patents

Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases

Info

Publication number
HUP0102702A2
HUP0102702A2 HU0102702A HUP0102702A HUP0102702A2 HU P0102702 A2 HUP0102702 A2 HU P0102702A2 HU 0102702 A HU0102702 A HU 0102702A HU P0102702 A HUP0102702 A HU P0102702A HU P0102702 A2 HUP0102702 A2 HU P0102702A2
Authority
HU
Hungary
Prior art keywords
basis
pharmaceutical composition
fatty acid
acid salts
skin diseases
Prior art date
Application number
HU0102702A
Other languages
Hungarian (hu)
Inventor
Ulrich Knie
Original Assignee
Dr. August Wolff Gmbh. & Co. Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. August Wolff Gmbh. & Co. Arzneimittel filed Critical Dr. August Wolff Gmbh. & Co. Arzneimittel
Publication of HUP0102702A2 publication Critical patent/HUP0102702A2/en
Publication of HUP0102702A3 publication Critical patent/HUP0102702A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
HU0102702A 1999-04-19 2000-04-03 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases HUP0102702A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19917548A DE19917548A1 (en) 1999-04-19 1999-04-19 Stable topical pharmaceutical composition for treating skin diseases, especially acne, contains erythromycin higher fatty acid salt in liquid or viscous carrier
PCT/EP2000/002950 WO2000062784A1 (en) 1999-04-19 2000-04-03 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases

Publications (2)

Publication Number Publication Date
HUP0102702A2 true HUP0102702A2 (en) 2001-12-28
HUP0102702A3 HUP0102702A3 (en) 2003-02-28

Family

ID=7905021

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102702A HUP0102702A3 (en) 1999-04-19 2000-04-03 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases

Country Status (11)

Country Link
EP (1) EP1085883A1 (en)
AU (1) AU4115100A (en)
BG (1) BG105093A (en)
DE (1) DE19917548A1 (en)
EE (1) EE200000727A (en)
HR (1) HRP20000884A2 (en)
HU (1) HUP0102702A3 (en)
NO (1) NO20006260L (en)
PL (1) PL344988A1 (en)
SK (1) SK18652000A3 (en)
WO (1) WO2000062784A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114632139B (en) * 2022-04-02 2023-04-07 北京双吉制药有限公司 Erythromycin ointment and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383667A1 (en) * 1977-03-16 1978-10-13 Desjonqueres Stephane Topical erythromycin compsns. - for treating acne, in hydrating or oily excipient
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
IT1210608B (en) * 1980-12-08 1989-09-14 Rorer Int Overseas COMPOSITION FOR TOPICAL ACNE TREATMENT
EP0109102B1 (en) * 1982-10-15 1988-01-20 THE PROCTER & GAMBLE COMPANY Storage stable topical pharmaceutical composition including nitrogen-containing stabilizers
JPS6021831A (en) * 1983-07-11 1985-02-04 コ−ニング・グラス・ワ−クス Glass for cathode ray tube face plate
LU86945A1 (en) * 1987-07-17 1989-03-08 Oreal PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON PYRIDONES AND ANTIBACTERIAL AGENTS
DE19706979A1 (en) * 1997-02-21 1998-08-27 Lindopharm Gmbh Combination preparation for oral erythromycins

Also Published As

Publication number Publication date
PL344988A1 (en) 2001-11-19
NO20006260D0 (en) 2000-12-08
WO2000062784A1 (en) 2000-10-26
DE19917548A1 (en) 2000-10-26
EE200000727A (en) 2002-04-15
EP1085883A1 (en) 2001-03-28
HRP20000884A2 (en) 2001-10-31
AU4115100A (en) 2000-11-02
HUP0102702A3 (en) 2003-02-28
NO20006260L (en) 2001-02-19
SK18652000A3 (en) 2001-08-06
BG105093A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
HK1037861A1 (en) Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
IL127943A0 (en) Pharmaceutical and cosmetic composition for the treatment of skin disorders
AU1773600A (en) Topical treatment of skin disease
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
ATE285779T1 (en) MEDICINAL COMPOSITION CONTAINING CICLESONIDE FOR ADMINISTRATION TO THE MUCOUS MEASURES
HUP0102702A3 (en) Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases
GB0026923D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
IL150122A0 (en) Remedies for external use for allergic skin diseases
AU2900100A (en) Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
AU6439400A (en) Skin cosmetic compositions for reducing skin irritation from weak carboxylic acids
AU1022501A (en) Use of compositions for the caring treatment of the skin
AR024100A1 (en) AMIDAS OF SUBSTITUTED PHENILCICLOHEXANOCARBOXILIC ACIDS
AU2001282410A1 (en) N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer
IL136342A0 (en) Formulation for topical treatment of skin infections
ZA97253B (en) Topical compositions for the treatment of skin diseases
HU9800835D0 (en) Pharmaceutical composition for treatment diseases causing by ascophaera apis
AU4101900A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
PL350327A1 (en) Compositions for the treatment of skin diseases
AU5759500A (en) Methods for ameliorating icthyosiform skin diseases
AU7599700A (en) Use of anti-inflammatory drugs for treatment of dermatological conditions
NO20031080D0 (en) Fatty acid analogues for the treatment of profiling skin diseases
AU5523298A (en) Novel topical formulation of anti-inflammatory drugs for the treatment of localized pain
AUPQ902000A0 (en) Pharmaceutical composition for the treatment of skin conditions